Announcements Trials
Browse Landscape Eligibility

Clinical Trials

1 trials
RecentStart dateEnrollment
NF1 × Clear all

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Breast Neoplasms 12989Neoplasms 10382Carcinoma, Non-Small-Cell Lung 6793Prostatic Neoplasms 6196Colorectal Neoplasms 5862Lung Neoplasms 5040Multiple Myeloma 3541Pancreatic Neoplasms 3511Neoplasm Metastasis 3478Leukemia, Myeloid, Acute 3467Carcinoma, Hepatocellular 3227Ovarian Neoplasms 3138Melanoma 3120Stomach Neoplasms 3019Lymphoma 2970Head and Neck Neoplasms 2575Recurrence 2527Precursor Cell Lymphoblastic Leukemia-Lymphoma 2485Leukemia 2353Colonic Neoplasms 2317Brain Neoplasms 2293Lymphoma, Non-Hodgkin 2257Rectal Neoplasms 2171Uterine Cervical Neoplasms 2164Glioblastoma 1993Leukemia, Lymphocytic, Chronic, B-Cell 1985Carcinoma, Renal Cell 1897Squamous Cell Carcinoma of Head and Neck 1856Lymphoma, Follicular 1829Esophageal Neoplasms 1786

Interventions

mirdametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT06159166 2026-04-13

Mirda

Johns Hopkins University

Phase 1/2 Recruiting
24 enrolled
CNSDermatologic

NF1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡